BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29902745)

  • 21. The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease.
    Cheng-Hathaway PJ; Reed-Geaghan EG; Jay TR; Casali BT; Bemiller SM; Puntambekar SS; von Saucken VE; Williams RY; Karlo JC; Moutinho M; Xu G; Ransohoff RM; Lamb BT; Landreth GE
    Mol Neurodegener; 2018 Jun; 13(1):29. PubMed ID: 29859094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of two Alpha-I antitrypsin deficiency patient-derived induced pluripotent stem cell lines ISRM-AATD-iPSC-1 (HHUUKDi011-A) and ISRM-AATD-iPSC-2 (HHUUKDi012-A).
    Ncube A; Bewersdorf L; Spitzhorn LS; Loerch C; Bohndorf M; Graffmann N; May L; Amzou S; Fromme M; Wruck W; Strnad P; Adjaye J
    Stem Cell Res; 2023 Sep; 71():103171. PubMed ID: 37506509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
    Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
    Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and characterization of two iPSC lines from human epicardium-derived cells.
    Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
    Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of iPSC line epiHUVEC from human umbilical vein endothelial cells.
    Matz P; Adjaye J
    Stem Cell Res; 2015 Nov; 15(3):581-3. PubMed ID: 26987922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
    Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
    Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
    Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
    Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rare TREM2 variants associated with Alzheimer's disease display reduced cell surface expression.
    Sirkis DW; Bonham LW; Aparicio RE; Geier EG; Ramos EM; Wang Q; Karydas A; Miller ZA; Miller BL; Coppola G; Yokoyama JS
    Acta Neuropathol Commun; 2016 Sep; 4(1):98. PubMed ID: 27589997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
    Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
    Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
    Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
    Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-derived integration-free iPS cell line UKBi011-A from a diagnosed male Alzheimer's disease patient with APOE ɛ4/ɛ4 genotype.
    Peitz M; Bechler T; Thiele CC; Veltel M; Bloschies M; Fliessbach K; Ramirez A; Brüstle O
    Stem Cell Res; 2018 May; 29():250-253. PubMed ID: 29753274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blood mononuclear cell-converted induced pluripotent stem cells (iPSCs) from an early onset Alzheimer's patient.
    Lee HK; Morin P; Xia W
    Stem Cell Res; 2016 Mar; 16(2):213-5. PubMed ID: 27345971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
    Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
    Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
    Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D
    J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Episomal plasmid-based generation of an iPSC line from a 79-year-old individual carrying the APOE4/4 genotype: i11001.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):544-546. PubMed ID: 27789405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivation of an induced pluripotent stem cell line (MUSIi004-A) from dermal fibroblasts of a 48-year-old spinocerebellar ataxia type 3 patient.
    Ritthaphai A; Wattanapanitch M; Pithukpakorn M; Heepchantree W; Soi-Ampornkul R; Mahaisavariya P; Triwongwaranat D; Pattanapanyasat K; Vatanashevanopakorn C
    Stem Cell Res; 2018 Jul; 30():113-116. PubMed ID: 29852467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.
    Sudom A; Talreja S; Danao J; Bragg E; Kegel R; Min X; Richardson J; Zhang Z; Sharkov N; Marcora E; Thibault S; Bradley J; Wood S; Lim AC; Chen H; Wang S; Foltz IN; Sambashivan S; Wang Z
    J Biol Chem; 2018 Aug; 293(32):12634-12646. PubMed ID: 29794134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of the Human iPSC Line from Spontaneous Late-Onset Alzheimer's Disease Patient with ApoE3/3 Genotype and Sex-, Age-, and ApoE-Matched Healthy Control.
    Kadakova S; Raska J; Hribkova H; Fedorova V; Sedmik J; Plesingrova K; Sheardova K; Bohaciakova D
    Stem Cell Res; 2024 Feb; 74():103273. PubMed ID: 38100913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.